A 6-Month Prospective Study on Efficacy, Safety, and Quality of Life Profiles of Extended-Release Formulation of Valproate in Patients with Epilepsy

    October 2010 in “ Seizure ”
    Peimin Yu, Guangfa Zhu, Xunyi Wu, Ting Li, Lan Xu, Yue Li, Bei Wang, Zhen Hong
    Image of study
    TLDR Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.
    In a 6-month prospective study involving 958 epilepsy patients, the extended-release (ER) formulation of valproate was evaluated for efficacy, safety, and quality of life impact. The study found that the ER valproate, used as initial or add-on therapy, significantly reduced seizure frequency by 88.3% from a baseline mean of 8.56 seizures per month, with patients taking a median maintenance dose of 750 mg per day. Quality of life improvements were noted in areas such as seizure worry, overall quality of life, and social function, although energy levels decreased. Early treatment side effects included drowsiness, dizziness, and anorexia, while weight gain, alopecia, and tremor were reported after 6 months. Overall, the ER valproate was shown to be effective in reducing seizures with good tolerance and enhanced quality of life for patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 5 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Androgenic alopecia exclusively on the vertex of the scalp

      in Chat  6 upvotes 7 months ago
      A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hair loss is common among men.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 9 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Similar Research

    6 / 1000+ results